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Pfanzagl B, Zevallos VF, Schuppan D, Pfragner R, Jensen-
Jarolim E. Histamine causes influx via T-type voltage-gated calcium
channels in an enterochromaffin tumor cell line: potential therapeutic
target in adverse food reactions. Am J Physiol Gastrointest Liver
Physiol 316: G291–G303, 2019. First published December 12, 2018;
doi:10.1152/ajpgi.00261.2018.—The P-STS human ileal neuroendo-
crine tumor cells, as a model for gut enterochromaffin cells, are
strongly and synergistically activated by histamine plus acetylcholine
(ACh), presumably via histamine 4 receptors, and weakly activated by
histamine alone. Sensing these signals, enterochromaffin cells could
participate in intestinal intolerance or allergic reactions to food con-
stituents associated with elevated histamine levels. In this study we
aimed to analyze the underlying molecular mechanisms. Inhibition by
mepyramine and mibefradil indicated that histamine alone caused a
rise in intracellular calcium concentration ([Ca2]i) via histamine 1
receptors involving T-type voltage-gated calcium channels (VGCCs).
Sensitivity to histamine was enhanced by pretreatment with the
inflammatory cytokine tumor necrosis factor- (TNF-). In accor-
dance with the relief it offers some inflammatory bowel disease
patients, otilonium bromide, a gut-impermeable inhibitor of T-type
(and L-type) VGCCs and muscarinic ACh receptors, efficiently in-
hibited the [Ca2]i responses induced by histamine plus ACh or by
histamine alone in P-STS cells. It will take clinical studies to show
whether otilonium bromide has promise for the treatment of adverse
food reactions. The cells did not react to the nutrient constituents
glutamate, capsaicin, cinnamaldehyde, or amylase-trypsin inhibitors
and the transient receptor potential channel vanilloid 4 agonist GSK-
1016790A. The bacterial product butyrate evoked a rise in [Ca2]i
only when added together with ACh. Lipopolysaccharide had no
effect on [Ca2]i despite the presence of Toll-like receptor 4 protein.
Our results indicate that inflammatory conditions with elevated levels
of TNF- might enhance histamine-induced serotonin release from
intestinal neuroendocrine cells.
NEW & NOTEWORTHY We show that histamine synergistically
enhances the intracellular calcium response to the physiological ago-
nist acetylcholine in human ileal enterochromaffin tumor cells. This
synergistic activation and cell activation by histamine alone largely
depend on T-type voltage-gated calcium channels and are inhibited by
the antispasmodic otilonium bromide. The cells showed no response
to wheat amylase-trypsin inhibitors, suggesting that enterochromaffin
cells are not directly involved in nongluten wheat sensitivity.
amylase trypsin inhibitors; calcium channels; enterochromaffin; his-
tamine; otilonium bromide
INTRODUCTION
At present, the triggers of adverse food reactions in
individual patients are not entirely predictable. Innate mech-
anisms and neuronal factors may amplify the reactions,
especially with preexisting inflammatory conditions. While
most research so far has been dedicated to mast cells,
eosinophils, and macrophages, we propose here that entero-
chromaffin (EC) cells might participate in and amplify
adverse food symptoms or impact the threshold levels for
clinical symptoms.
EC cells are dispersed throughout the intestinal mucosa
and release serotonin (5-hydroxytryptamine) to the serosal
side upon stimulation by nutrients or other chemical medi-
ators, acidic pH, or mechanical distortion (6, 25). Their
apical microvilli project in the gut lumen. They are found in
close contact to nerve endings of submucosal neurons of the
enteric reflex pathways, which are largely cholinergic (26,
36). Cholinergic agonists like acetylcholine (ACh) induce a
rise in intracellular calcium ([Ca2]i) that triggers exocyto-
sis of serotonin-containing vesicles to the basolateral side
(46). ACh (26) and serotonin (21, 29, 62) enhance gut
secretion and motility, and high levels of serotonin can
cause diarrhea (60). A role of serotonin in the pathology of
inflammatory bowel disease, diarrhea-predominant irritable
bowel syndrome (IBS), and celiac disease is also discussed
(19, 20, 30).
The P-STS cell line (45, 48), isolated from a poorly
differentiated neuroendocrine tumor of the terminal ileum,
grows with a stable genotype (48) and was established as a
reliable EC cell line by showing stable expression of the
neuroendocrine vesicle components and tryptophanhy-
droxylase-1, the rate-limiting enzyme for synthesis of sero-
tonin expressed specifically in enteroendocrine cells (44).
The neuroendocrine identity of P-STS cells was confirmed
by Hofving et al. (27), as was the neuroendocrine origin of
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the GOT1 cell line derived from a liver metastasis of an ileal
serotonin-producing tumor. To date, these two cell lines are
the only established models for human intestinal serotonin-
producing (EC) cells (24). The higher serotonin content of
GOT1 cells (27) suggests that they might be suitable for
studies of serotonin secretion, while the P-STS cell line
contains only a small amount of serotonin (44). Whether
GOT1 cells like P-STS cells respond to a physiologically
appropriate stimulus like ACh (44) apparently has not been
investigated.
P-STS cells react to histamine with a strong increase in
[Ca2]i when it is added simultaneously with ACh that
exceeds the [Ca2]i increase evoked by ACh alone (44).
There was also a similar reaction in the presence of ACh
with the histamine 4 receptor (H4R) ligand 4-methylhista-
mine (4-mHA), suggesting an involvement of H4R. We now
established that the [Ca2]i response to ACh plus histamine
is more than additive. There was also a weak response to
histamine 1 receptor (H1R) that had not been noticed pre-
viously. We investigated the role of external calcium and of
L-, N-, P-, R-, and T-type voltage-gated calcium channels
(VGCC) in the responses of P-STS cells to ACh and
histamine. Voltage-dependent calcium currents in primary
ileal neuroendocrine tumor cells cultivated for a few days
have been attributed mainly to L-type VGCC (22). Influx of
calcium can also be mediated by transient receptor potential
(TRP) channels. Some of them can be activated by food
constituents like cinnamaldehyde [transient receptor poten-
tial channel ankyrin 1 (TRPA1)], capsaicin [transient recep-
tor potential channel vanilloid 1 (TRPV1)], or piperine
(TRPA1 and TRPV1). TRPA1, TRPV1, and transient recep-
tor potential channel vanilloid 4 (TRPV4) have been impli-
cated in nociception (5) and thus might be involved in IBS.
Accordingly, we also investigated the reaction of P-STS
cells to agonists of these channels.
Our search for other potential activators of serotonin
release present in greater amounts in the human diet in-
cluded the flavor enhancer glutamate and the short-chain
fatty acid butyrate produced by bacterial degradation of
fiber (57). The [Ca2]i response of P-STS cells to wheat
amylase-trypsin inhibitors (ATI) was also investigated. ATI
are nongluten proteins highly resistant to intestinal proteol-
ysis that are taken up with wheat and related cereals (67).
They activate the innate intestinal immune responses via
Toll-like receptor 4 (TLR4) on monocytes/macrophages or
dendritic cells (28), inducing the release of inflammatory
cytokines. As established for bacterial lipopolysaccharide
(LPS), these effects of ATI require the presence of CD14 as
part of the TLR4-MD2-CD14 complex.
METHODS
Cell culture. P-STS midgut neuroendocrine tumor cells [semi-
adherent, originally isolated from a World Health Organization III
neuroendocrine tumor of the terminal ileum (48)] were grown in a
1:1 mixture of medium-199 and Ham’s F-12 nutrient mixture
supplemented with 10% heat-inactivated fetal calf serum, 100
U/ml penicillin G, and 100 g/ml streptomycin at 37°C in a
humidified atmosphere containing 5% CO2. HEK 293 human
embryonic kidney cells and THP-1 monocytes were grown in
DMEM and RPMI 1640 medium, respectively, containing the same
supplements. THP-1 cells were differentiated for 2 days with 200
nM phorbol 12-myristate,13-acetate (PMA) before immunofluo-
rescence staining or treatment with LPS. All cell lines were tested
for mycoplasma contamination by staining with Hoechst dye
33342.
Antibodies and reagents. Mouse anti-human TLR4 antibody
(clone 76B357.1) was from Novus Biologicals (Littleton, CO);
rabbit anti-human phospho-NF-B p65(Ser536) (clone 93H1) was
from Cell Signaling Technology (Cambridge, UK); mouse anti-
human RelA/NF-B p65 (clone 532301) and recombinant human
tumor necrosis factor- (TNF-) were from R&D Systems (Min-
neapolis, MN); rabbit anti-human TRPV4 (directed against an
epitope in the middle region) and the corresponding blocking
peptide were from Aviva Systems Biology (San Diego, CA); Alexa
Fluor 647-labeled mouse anti-human CD14 was from Biolegend
(San Diego, CA); goat Alexa Fluor 488-labeled secondary fluores-
cent antibodies and fluo 4-AM were from Life Technologies
(Carlsbad, CA); mouse anti-human H1R (G-11) and the corre-
sponding blocking peptide as well as anti-mouse IgG-horseradish
peroxidase were from Santa Cruz Biotechnology (Dallas, TX);
-agatoxin IVA, 4-methylhistamine dihydrochloride, mepyramine
maleate, mibefradil dihydrochloride, and rantidine hydrochloride
were from Tocris (Bristol UK); -conotoxin GVIA was from
Smartox Biotechnology (Saint-Egrève, France); SNX-482 was
from Peptanova (Sandhausen, Germany); otilonium bromide was
from Seleckchem (Munich, Germany); L-epinephrine, capsaicin,
piperine, trans-cinnamaldehyde (99%), A-23187 Ca2 ionophore,
nifedipine, GSK-1016790A, PMA, LPS from Escherichia coli
055:B5, bovine serum albumin (98%), ACh chloride, histamine
dihydrochloride, monosodium L-glutamic acid, and sodium bu-
tyrate were from Sigma Aldrich (St. Louis, MO).
Isolation of wheat ATI. Wheat ATI was isolated as described
elsewhere (67). Briefly, wheat kernels were ground to flour, sieved
(250 m), defatted with methanol/diethylether, dried, and ex-
tracted with 50 mM ammonium bicarbonate/0.3 M sodium chloride
(pH 7.8) at 4°C. The extract was fractionated with ammonium
sulfate. The fraction precipitating between 1.8 and 4 M ammonium
sulfate was redissolved, extensively dialyzed against 10 mM am-
monium bicarbonate/0.3 M sodium chloride (pH 7.8), cleared by
centrifugation, filtered (0.22 m), and freeze-dried, resulting in a
preparation with an ATI content of ~60% of total protein known to
contain mainly the isoforms CM3, 0.19, and 0.28, as determined by
mass spectrometry (67). Biological activity and endotoxin content
below 0.1 ng/mg were ascertained as described elsewhere (67).
Before use, the ATI preparation was resuspended in water at a
concentration of 30 mg dry wt/ml.
Immunofluorescence microscopy and [Ca2]i imaging. For immu-
nofluorescence microscopy, cells were grown on cover slips and
analyzed as described previously (44). Briefly, cells were fixed
with 4% paraformaldehyde in phosphate-buffered saline (PBS) and
permeabilized for 5 min with 0.2% vol/vol Triton X-100 in PBS.
Blocking and incubation with antibodies took place in 5% fetal calf
serum in PBS at room temperature. Nuclei were stained with
Hoechst dye 33342. Where indicated, antibodies were preincu-
bated for 2 h at room temperature with or without a fivefold
(weight/weight) amount of blocking peptide corresponding to their
epitope before addition to the fixed and permeabilized cells.
[Ca2]i imaging with fluo 4-AM, quantification with Image J, and
statistical analysis of [Ca2]i responses from ranked data with the
unpaired two-tailed t-test assuming unequal variances were done as
described previously (44). Briefly, the cells were grown in 24-well
plates to very low density and stained 45 min at room temperature
with fluo 4-AM in serum-free medium. The medium was exchanged
for 200 l of pure medium, and, after 25 min of incubation at room
temperature, photographs were taken before and after careful addition
of potential agonists in 200 l pure medium. The [Ca2]i response of
fluo 4-AM-stained P-STS cells to addition of the indicated substances
was determined as fluorescence enhancement 10 s after the start of
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substance addition in relation to baseline fluorescence, if not indicated
otherwise. The number of experiments conducted (n) is given in the
legends for Figs 1–10.
For evaluation of the effect of external calcium, cells were washed
two times with HEPES-buffered saline, pH 7.4, without Ca2 after
incubation with fluo 4-AM and then incubated for 25 min in the same
buffer with or without 1 mM Ca2 before agonist addition.
RNA isolation, reverse transcription, and polymerase chain
reaction. RNA from 50% confluent P-STS cells was isolated,
purified, and quantified with TRIzol (Thermo Fisher Scientific,
Waltham, MA) following the manufacturer’s instructions. In a total
volume of 20 l, cDNA was synthesized from 0.7 g RNA using
the iScriptcDNA Synthesis Kit (Bio-Rad) as described by the
manufacturer and kept at 20°C until use. Polymerase chain
reaction (PCR) amplifications were performed with 0.1 l cDNA.
Thermus aquaticus Taq DNA polymerase and deoxynucleotides
were from Sigma Aldrich. The amplification process was started
with incubation at 95°C for 5 min. After 35– 42 cycles (see below)
elongation was completed for 7 min at 72°C. The following primer
pairs (ordered from Thermo Fisher Scientific) and PCR conditions
were used successfully: human H4R forward 5=-CCG TTT GGG
TGC TGG CCT TCT TAG-3= and reverse 5=-GAT CAC GCT TCC
ACA GGC TCC AAT-3= [product size 204 bp (55)] with 1.5 mM
MgCl2 and 40 cycles (30 s at 95°C, 30 s at 60°C, 1 min at 72°C);
human TRPV4 forward 5=-GAG AAC ACC AAG TTT GTC ACC
A-3= and reverse 5=-TGA ATC ATG ATG CTG TAG GTC C-3=
[product size 632 and 812 bp (32)] with 2.5 mM MgCl2 and 42
cycles (30 s at 95°C, 1 min at 60°C, 1 min at 72°C); human H1R
PrimerBank (53) primer pair ID 149158708c2 (forward 5=-CTG
AGC ACT ATC TGC TTG GTC-3= and reverse 5=-AGG ATG TTC
ATA GGC ATG ACG A-3=, product size 158 bp) with 1.5 mM
MgCl2 and 35 cycles (30 s at 95°C, 1 min at 54°C, 1 min at 72°C);
human free fatty acid receptor 2 (FFAR2) PrimerBank primer pair
ID 227430361c2 (forward 5=-TGC TAC GAG AAC TTC ACC
GAT-3= and reverse 5=-GGA GAG CAT GAT CCA CAC AAA
AC-3=, product size 135 bp, conditions as for human H4R); human
free fatty acid receptor 3 (FFAR3) PrimerBank primer pair ID
209862766c2 (forward 5=-GCG TGG AGG ATC TAC GTG AC-3=
and reverse 5=-TGT GAG TGT TCA CTG GTC TTT C-3=, product
size 233 bp) with 1.5 mM MgCl2 and eight cycles with annealing
at 60°C (30 s at 95°C, 30 s at 60°C, 1 min at 72°C) plus 32 cycles
at 54°C (30 s at 95°C, 1 min at 54°C, 1 min at 72°C); human TLR4
PrimerBank primer pair ID 373432602c1 (forward 5=-AGA CCT
GTC CCT GAA CCC TAT-3= and reverse 5=-CGATGGACTT-
CTAAACCAGCCA-3=, expected product 147 bp, conditions as for
human H4R). PCR products and Thermo Scientific GeneRuler
DNA Ladder Mix were separated on 1% agarose and stained with
ethidium bromide.
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Fig. 1. The intracellular calcium concentration
([Ca2]i) response of fluo 4-AM-stained P-STS
cells to histamine and other substances. For pre-
incubation (PI), the indicated substances were
added to the cells 10 min before agonist addition.
HA, histamine. *P 	 0.05 and **P 	 0.01. A:
synergistic enhancement of cell activation by si-
multaneous addition of 1 M ACh and 10 M
histamine. The sum of the fluorescence enhance-
ment by addition of ACh or histamine alone cal-
culated separately for each experiment [(ACh 
HA)] was compared with fluorescence enhance-
ment after simultaneous addition (4th column,
n 
 18). B: histamine (10 M) also enhances the
[Ca2]i response to ACh when added 10 min
earlier (n 
 9). C: the Ca2 ionophore A-23187
(100 nM) did not enhance the [Ca2]i response to
10 M histamine or 1 M ACh (n 
 12 and 6,
respectively). D: histamine (10 M), but not the
histamine 4 receptor (H4R) agonist 4-methylhista-
mine (4-mHA, 10 M), causes cell activation when
added alone (n
 8, left). Activation by histamine is
inhibited by preincubation with the histamine 1
receptor (H1R) inhibitor mepyramine (1 M, n
 6,
right). E: preincubation with the histamine 2 recep-
tor (H2R) antagonist ranitidine (10 M) had no
significant effect on the [Ca2]i response to hista-
mine (n 
 13). Because cells reacted slowly in this
experiment, significance was calculated from mea-
surements taken 20 s after substance addition.
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Statistical analysis of [Ca2]i imaging experiments. Because it was
obvious that increases in fluorescence calculated from the [Ca2]i
imaging experiments were not normally distributed, statistical signif-
icance of the difference of mean values was calculated from ranked
data with the unpaired two-tailed t-test assuming unequal variances
(for a detailed discussion, see Ref. 44). To increase statistical reliabil-
ity and strength, treatments were always conducted in parallel, result-
ing in equal sample numbers in each treatment group.
RESULTS
The [Ca2]i response to ACh is synergistically enhanced by
histamine while histamine alone evokes a small [Ca2]i rise
via H1R. P-STS cells reacted with a strong increase in [Ca2]i
to histamine or the H4R agonist 4-mHA when added together
with a small amount of ACh (44), while histamine or 4-mHA
alone did not evoke a significant response in these previous
experiments. Here we demonstrate that ACh and histamine in
fact acted synergistically in this cell activation when added
simultaneously (Fig. 1A) and were equally effective when
histamine was added 10 min before ACh (Fig. 1B). In our
previous work (44) we suggested that the observed synergism
of ACh and histamine might simply be the result of an
elevation of [Ca2]i when either compound caused an in-
creased reaction to the second compound. A thorough investi-
gation now showed that the reactions to histamine or ACh
alone were not significantly influenced by increasing [Ca2]i
with the calcium ionophore A-23187 (Fig. 1C).
Further experiments showed that 10 M histamine alone
elicited a small rise in [Ca2]i not observed with the H4R
agonist 4-mHA alone (Fig. 1D, left). This reaction, unnoticed
in our previous investigations (44), was completely inhibited
by the H1R antagonist mepyramine (Fig. 1D, right). In our
previous work (44) we showed that histamine 3 receptor (H3R)
activation had an inhibitory effect on the [Ca2]i response of
P-STS cells to ACh, ACh plus histamine, or histamine alone.
We did not detect any effect of the histamine 2 receptor (H2R)
antagonist ranitidine on the [Ca2]i response of P-STS cells to
ACh or ACh plus histamine. Here we tested the effect of
ranitidine on cell activation by histamine alone, but again
without any significant effect (Fig. 1E). In addition, the [Ca2]i
response of P-STS cells to ACh and epinephrine was compared
(Fig. 2). The cells reacted only weakly to a challenge with 100
M epinephrine while showing a strong response to 1 M
ACh.
T-type VGCCs play a prominent role in the [Ca2]i re-
sponse to ACh and histamine. Experiments conducted in me-
dium prepared without Ca2 indicated a contribution of exter-
nal Ca2 to the [Ca2]i response to ACh or histamine (Fig. 3).
To define the pathway of Ca2 influx, several inhibitors of
VGCCs were tested for their ability to reduce cell activation by
ACh (Fig. 4A) and ACh plus histamine (Fig. 4B). Inhibitors of
L-, N-, P-, and R-type VGCCs {nifedipine [5 M, IC50 ~0.3
M for L-type channels (50)], -conotoxin GVIA, -agatoxin
IVA, and SNX-482, respectively} had no significant effect,
whereas the T-type channel inhibitor mibefradil [5 M, IC50
~0.3 M for T-type channels (54)] effectively reduced the
increase in [Ca2]i in response to ACh and ACh plus hista-
mine. Likewise, only mibefradil inhibited the [Ca2]i increase
1
1.1
1.2
1.3
*
**
re
la
tiv
e 
flu
or
es
ce
nc
e 
in
cr
ea
se
 a
fte
r s
ub
st
an
ce
 a
dd
iti
on
ep
ine
ph
rin
e 1
0μ
M
ep
ine
ph
rin
e 1
00
μM
Fig. 2. Comparison of the intracellular calcium concentration ([Ca2]i) re-
sponse of P-STS cells to epinephrine, histamine, and ACh. Epinephrine,
histamine, or ACh was added to the cells at the indicated concentrations, and
the increase in fluo 4-AM fluorescence was determined (n
 7). *P	 0.05 and
**P 	 0.01.
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Fig. 3. Influx of external Ca2 contributes to P-STS cell activation by ACh and
histamine. The cells were preincubated in HEPES-buffered saline (HBS) with
or without 1 mM Ca2 before addition of ACh (n 
 4) or histamine (n 
 8)
at the indicated concentrations. The intracellular calcium concentration
([Ca2]i) response of fluo 4-AM-stained P-STS cells was determined as
fluorescence enhancement 10 (ACh) or 20 (histamine) s after the start of
substance addition in relation to baseline fluorescence. HA, histamine
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induced by histamine alone (Fig. 4C), suggesting an important
role for T-type channels with all tested agonists without in-
volvement of L-type channels. The participation of P-, N-, and
R-type channels in the response to the employed agonists
cannot be completely excluded, since the inhibitor concentra-
tions used were rather low to avoid unspecific inhibition.
Similar inhibitor concentrations were, however, inhibitory in
other systems (4, 42, 51).
An even better inhibitor than mibefradil was the antispas-
modic otilonium bromide, an inhibitor of T- and L-type chan-
nels (54), but also of muscarinic ACh receptors (35). It already
strongly inhibited the [Ca2]i response to ACh plus histamine
at a concentration of 1 M. In accordance with its ability to
block T-type channels at similar concentrations as mibefradil
(54), otilonium bromide (5 M) also inhibited the response to
histamine alone (Fig. 4D).
[Ca2]i response to agonists of TRPA1, TRPV1 and TRPV4.
A role in visceral nociception has been observed for TRPV1,
TRPA1, and TRPV4 (5). Upon stimulation, these channels
mediate influx of Ca2 and other cations. We tested the effect
of the TRPV1 agonist capsaicin from hot peppers, the TRPA1
agonist cinnamaldehyde from the spice cinnamon, and the
TRPV4 agonist GSK-1016790A on P-STS cells in the absence
(Fig. 5A) and presence (Fig. 5B) of ACh, all rendering no
significant effects on [Ca2]i. Piperine, an agonist of TRPV1
and TRPA1 and a constituent in pepper, was also without
effect (Fig. 5A). Visceral hypersensitivity induced by an ago-
nist of TRPV4 was previously found to be potentiated by
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Fig. 4. The T-type voltage-gated calcium chan-
nel (VGCC) inhibitor mibefradil inhibits the
intracellular calcium concentration ([Ca2]i)
response of P-STS cells to ACh, ACh plus
histamine, and histamine alone. For preincuba-
tion (PI) the indicated substances were added
to the cells 10 min before agonist addition. HA,
histamine. *P 	 0.05. A and B: preincubation
with mibefradil (5 M), but not nifedipine
(5 M), -agatoxin IVA (50 nM), -conotoxin
GVIA (5 nM), or SNX-482 (500 nM), inhibits
the [Ca2]i response to 1 M ACh (A, left: n

10, right: n 
 5) and 1 M ACh plus 10 M
histamine (B, left: n 
 8, right: n 
 5). C:
preincubation with mibefradil (5 M) inhibits
the [Ca2]i response to histamine (n 
 8). D:
preincubation with otilonium bromide inhibits
the [Ca2]i response to 1 M ACh plus 10 M
histamine (n 
 8, 1 M otilonium bromide)
and to 10 M histamine (n 
 10, 5 M
otilonium bromide). Here the P value is slightly
higher than 0.05, but, as detailed previously (44),
with strong agonists like ACh plus histamine, the
applied rank test tends to underestimate signifi-
cance because of a strongly right-skewed fre-
quency distribution.
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histamine in vivo and in isolated sensory neurons (14). Like-
wise, a prominent role of TRPV4 has been seen in cell
activation by histamine in human keratinocytes (15), as has a
facilitation of GSK-1016790A-induced signaling by TRPV1 in
HEK 293 cells expressing TRPV1 and TRPV4 (32). This led
us to investigate whether preincubation with different combi-
nations of histamine, capsaicin, and GSK-1016790A had an
effect on cell activation by small amounts of ACh (Fig. 5C),
but no significant enhancement was detected. Notably, in this
experiment the histamine concentration was only 2 M, a
concentration that does not always show a clear enhancing
effect on the ACh-induced [Ca2]i response (also see Ref. 44).
This histamine concentration was chosen to allow for further
enhancements of [Ca2]i by coadded substances.
[Ca2]i response to selected nutrient components and deg-
radation products. More important dietary constituents like
glutamate, butyrate (a fiber degradation product produced in
the intestine), and ATI were tested for their effect on [Ca2]i in
PSTS cells. None of these compounds caused cell activation
when added alone (Fig. 6, A and C). The increase in fluores-
cence upon addition of ATI apparently was because of auto-
fluorescence of ATI, as shown by comparison with ATI added
to Hoechst dye 33342-stained fixed cells instead of live fluo
4-AM-stained cells using the same experimental procedure
(Fig. 6C), and by the fact that, after the initial increase in
fluorescence resulting from ATI addition (ATI autofluores-
cence), there was no further change in fluorescence (Fig. 6E).
Because ATI have been shown to activate TLR4, the reaction
of P-STS cells to the TLR4 ligand LPS was tested for com-
parison (Fig. 6C). Even in the presence of 1% heat-inactivated
fetal calf serum, which effectively supplemented components
of the TLR4 signaling pathway in intestinal epithelial cells
(13), [Ca2]i showed no response to LPS (Fig. 6D). Glutamate
and butyrate were also added together with ACh (Fig. 6A).
Although glutamate was without significant effect, butyrate
strongly enhanced the response to ACh. In this series of
experiments (Fig. 6A), the reaction to 1 M ACh was very
weak, which prompted additional experiments. The enhancing
effect of butyrate on the response to ACh remained significant
(Fig. 6B).
Effect of long incubation with histamine, ATI, LPS, or
TNF- on [Ca2]i responses to agonists. Because histamine,
ATI, or TNF- are all substances with a suspected role in
delayed food-intolerance reactions, IBS, or inflammatory
bowel disease (IBD), we further tested whether longer incuba-
tion with these substances would have an effect on the suscep-
tibility of P-STS cells to histamine. Preincubation with hista-
mine for 18–20 h before removal of the medium and start of
the labeling procedure for [Ca2]i imaging appeared to desen-
sitize P-STS cells to histamine, ACh, and ACh plus histamine
(Fig. 7A). Preincubation with ATI or LPS had no enhancing
effect on the response to histamine or ACh plus histamine (Fig.
7, B and C). After preincubation with TNF-, implicated in
tissue inflammation in IBD, there was still no response to ATI
(Fig. 7E) or LPS (Fig. 7D) but an enhanced response to
histamine alone (Fig. 7D). The response to ACh plus histamine
was too variable to allow any conclusion to be drawn (Fig. 7D).
P-STS cells express H1R, H4R, FFAR2, FFAR3, TRPV4, and
TLR4 mRNA. Our [Ca2]i imaging experiments indicated that
P-STS cells expressed functional H1R and H4R and suggested
expression of the short-chain fatty acid receptors FFAR2 or
FFAR3 because the cells reacted to butyrate in the presence of
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Fig. 5. Effect of transient receptor potential (TRP) channel agonists on the intracellular calcium concentration ([Ca2]i) response of P-STS cells to ACh, ACh
plus histamine, or histamine alone. For preincubation (PI) the indicated substances were added to the cells 10 min before agonist addition. HA, histamine. A:
no [Ca2]i response is detectable with different TRP agonists (n 
 6–8, final DMSO concentration 0.02% because of preparation of some TRP agonist stocks
in DMSO). B: no [Ca2]i response is detectable with different TRP agonists added together with 1 M ACh (n 
 7, final DMSO concentration 0.02%). C:
combining the transient receptor potential channel vanilloid 1 (TRPV1) agonist capsaicin and the transient receptor potential channel vanilloid 4 (TRPV4) agonist
GSK-1016790A with each other or with histamine during preincubation had no discernible effect on the [Ca2]i response to ACh. Capsaicin, 50 nM;
GSK-1016790A, 100 nM; HA, 2 M; ACh, 1 M; n 
 8.
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ACh. This was confirmed by detection of the corresponding
mRNAs for all of those genes by PCR after reverse transcrip-
tion (Fig. 8). We also investigated the presence of TRPV4 and
TLR4 mRNAs. Although the cells did not respond to the
TRPV4 agonist GSK-1016790A or the TLR4 ligand LPS, the
mRNAs corresponding to these receptors were expressed (Fig.
8, lanes 3 and 14). Sequences for several of the primer pairs
used were from the PrimerBank project and were designed to
give good results with 40 cycles at 60°C with 1.5 mM MgCl2
and an annealing time of 30 s per cycle. This was confirmed for
the TLR4 primer pair ID373432602c1 and the FFAR2 primer
pair ID227430361c2 (Fig. 8, lanes 3 and 5). With the primer
bank primers ID209862766c1 and ID373432602c1 for FFAR3
and TRPV4, respectively, no PCR product was detectable
using these conditions (Fig. 8, lanes 7 and 8). A PCR product
of FFAR3 with the right size was obtained with the primer pair
ID209862766c2, albeit with different cycling conditions (Fig.
8, lane 10).
P-STS cells express H1R, TRPV4, TLR4, and CD14 protein.
Protein expression of H1R, TRPV4, TLR4, and CD14,
another component of the LPS receptor (Fig. 9D), was
verified by immunofluorescence microscopy using blocking
peptides or other cell lines as positive or negative controls
(Fig. 9).
NF-B activation after treatment with LPS is undetectable in
P-STS cells. Because TLR4 and CD14 protein was detected in
P-STS cells but without any [Ca2]i response to LPS, we
investigated whether LPS treatment would initiate NF-B
signaling in these cells. In addition to nuclear translocation of
the p65/RelA subunit of NF-B in the nucleus after release
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Fig. 6. Effect of selected nutrient components on
intracellular calcium concentration ([Ca2]i) of
P-STS cells. A: [Ca2]i response to glutamate
or butyrate added with or without 1 M ACh
(n 
 7). B: [Ca2]i response to butyrate (1 or
3 mM) added together with 1 M ACh (n 

14, including the 7 experiments shown in A).
C: fluorescence change upon addition of 300
g/ml of amylase-trypsin inhibitors (ATI) to
live (2nd column, n 
 5) or fixed (3rd column,
n 
 2) cells or Escherichia coli lipopolysac-
charide (LPS) to live cells (n 
 6) showing no
difference between the response of live and
fixed cells to ATI. D: [Ca2]i response to LPS
in the presence of fetal calf serum (FCS) to
supplement potentially missing factors. Heat-
inactivated FCS (1% vol/vol) was added to the
medium 25 min before substance addition. In
this experiment, the [Ca2]i response of fluo
4-AM-stained P-STS cells was determined as
fluorescence enhancement 20 s after the start
of addition of ACh (1 M, n 
 2) or LPS (10
g/ml, n 
 4) in relation to baseline fluores-
cence. E: time course of fluorescence increase
after addition of ATI compared with addition
of histamine (HA) or medium. As deduced
from C, the initial increase in fluorescence
after addition of ATI is the result of ATI
autofluorescence, but there is no further in-
crease in fluorescence with ATI, indicating a
lack of [Ca2]i response.
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from its complex with cytoplasmic IB following LPS-induced
IB phosphorylation, LPS is known to induce phosphorylation
of Ser536 of p65 and migration of the phosphorylated protein in
the nucleus as an early event of NF-B activation (39, 66).
Immunofluorescence microscopy showed that there was no
change in phospho-p65 staining in P-STS cells even after 270
min (Fig. 10B, top) while, in PMA-differentiated THP-1 cells,
p65/RelA phosphorylated at Ser536 migrated from the cyto-
plasm in the nucleus within 70 min after addition of LPS (Fig.
10A, top). Similarly, p65 distribution remained unchanged in
P-STS cells with LPS (Fig. 10B, bottom) while, in control
experiments in THP-1 cells, the p65 protein was found primar-
ily in the nucleus 21 h after LPS addition (Fig. 10A, bottom).
Treatment of P-STS cells with H2O2 for 30 min as a positive
control induced migration of p65/RelA in the nucleus (Fig.
10B, bottom).
DISCUSSION
Our work establishes that the previously observed (44)
enhancement of the reaction of P-STS cells to ACh by hista-
mine is not only additive but also synergistic. A more thorough
investigation of the effect of Ca2 ionophore added to either
ACh or histamine alone showed that this synergistic effect
re
la
tiv
e 
flu
or
es
ce
nc
e 
in
cr
ea
se
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
PI: TNF
p =
0.
01
4 
(c
om
pa
re
d 
to
 H
A)
AC
h H
A
AC
h H
AHA LP
S
me
diu
m HA
D
re
la
tiv
e 
flu
or
es
ce
nc
e 
in
cr
ea
se
 a
fte
r s
ub
st
an
ce
 a
dd
iti
on
E
re
la
tiv
e 
flu
or
es
ce
nc
e 
in
cr
ea
se
 a
fte
r s
ub
st
an
ce
 a
dd
iti
on
1
1.1
1.2
1.3
1.4
1.5
PI:150μM ATI
1
1.1
1.2
1.3
1.4
1.5
PI:1μg/ml LPS
0.9
1.0
1.1
1.2
1.3
1.4
1.5
1.6
1.7
-10 0 10 20 30
ATI 300μg/ml
ATI
PI:10ng/ml TNF
flu
or
es
ce
nc
e 
(a
rb
itr
ar
y 
un
its
)
seconds
AC
h H
A
AC
h H
A
AC
h H
A
AC
h H
AHA HA HA HA
B
1
1.1
1.2
1.3
1.4
1.5
1.6
1.7
1.8
PI:40μM HA
AC
h
AC
h
AC
h H
A
AC
h H
A HAHA
A C
re
la
tiv
e 
flu
or
es
ce
nc
e 
in
cr
ea
se
 a
fte
r s
ub
st
an
ce
 a
dd
iti
on
Fig. 7. Effect of prolonged incubation of P-
STS cells with histamine, amylase-trypsin in-
hibitors (ATI), lipopolysaccharide (LPS), or
tumor necrosis factor- (TNF-) on the reac-
tivity to agonists. For preincubation (PI) the
indicated substances were added to the cells
for 18–20 h, and the medium was exchanged
before staining with fluo 4-AM. HA, hista-
mine. If not indicated otherwise, ACh (1 M),
ACh (1 M) plus histamine (2 M), hista-
mine (10 M), LPS (10 g/ml), or ATI were
added to the cells, and the intracellular cal-
cium concentration ([Ca2]i) response was
measured. A: preincubation with histamine
(n 
 6). B: preincubation with ATI (n 
 5).
C: preincubation with LPS (because of high
reagibility of the cells only 0.5 M ACh was
added in these experiments, n 
 8). D: pre-
incubation with 10 ng/ml TNF- (n 
 6,
except for addition of histamine with n
 15).
E: time course of fluorescence increase after
addition of ATI to cells preincubated with 10
ng/ml TNF-. As deduced from Fig. 5C, the
initial increase in fluorescence after addition
of ATI is the result of ATI autofluorescence,
but there is no further increase in fluorescence
with ATI, indicating a lack of [Ca2]i re-
sponse.
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cannot be explained by a mere rise in [Ca2]i. The synergistic
effect of ACh and histamine is also seen when the cells are
preincubated with histamine before addition of ACh. This
suggests that pulses of ACh secreted by nerve endings and
reaching EC cells located in intestinal crypts could evoke a
similar response when histamine concentrations are elevated
following mast cell activation. Degranulated mucosal mast
cells and elevated histamine levels were detected in patients
with IBD and in a subset of IBS patients with increased
numbers of intestinal mast cells (reviewed in Refs. 7 and 33).
Multiple observations indicate a role of mast cells in gut
sensorimotor dysfunction and related diarrhea in IBD and IBS.
The susceptibility of P-STS cells to activation by histamine
suggests that these symptoms might be partly attributed to
increased serotonin release by EC cells in response to elevated
histamine secretion by mast cells.
In comparison with the strong response evoked by histamine
in the presence of ACh, presumably via H4R signaling (15), the
response to histamine alone appeared weak and may play a
minor role in serotonin secretion. Unfortunately, the low sero-
tonin content of P-STS cells does not allow easy detection of
secretion (44). Inhibition by the H1R antagonist mepyramine, a
first-generation antihistamine, showed that the [Ca2]i re-
sponse evoked by histamine alone is attributable to H1R
signaling. The H4R agonist 4-mHA alone did not cause any
significant [Ca2]i response. Regarding the other histamine
receptors, our previous work has demonstrated that the H3R
agonist methimepip had an inhibitory effect on P-STS activa-
tion by ACh, ACh plus histamine, or histamine alone (44). As
shown here, the H2R inhibitor ranitidine did not have any
significant effect on the [Ca2]i response evoked by histamine.
Epinephrine, an agonist sometimes used to stimulate secretion
in neuroendocrine cells, evoked only a very weak [Ca2]i
response in P-STS cells compared with ACh. This is in accor-
dance with the important physiological roles of ACh and
serotonin as excitatory stimuli of gut motility (43) and under-
lines the suitability of the P-STS cell line as a model for
intestinal serotonin-secreting cells.
Activation of H1R by histamine is known to mobilize intra-
cellular Ca2 stores and to cause influx of extracellular Ca2
via voltage-dependent and -independent ion channels in excit-
able cells (reviewed in Ref. 38). This influx of external calcium
is mainly responsible for secretion in response to histamine.
The [Ca2]i response to histamine, as well as to ACh alone,
was also augmented by external Ca2 in P-STS cells.
VGCC are thought to elevate Ca2 locally, and some of
them have been shown to interact directly with the secretory
machinery (see below). Additional Ca2 entry pathways like
TRP channels may trigger or modulate exocytosis (10, 41). We
investigated the participation of VGCC in the [Ca2]i response
of P-STS cells to histamine, ACh, or ACh plus histamine using
selective inhibitors for L-, N-, P-, R-, and T-type VGCC. Only
the T-type channel inhibitor mibefradil showed a significant
inhibitory effect. Mibefradil inhibited the [Ca2]i response for
histamine alone and for ACh and ACh plus histamine. In
contrast to the other VGCC channels mentioned, T-type VGCC
are low-voltage-activated channels that ensure secretion at
membrane potentials near the resting conditions important for
basal hormone release or sustained release during mild stimu-
lations (reviewed in Refs. 12 and 63). There is ample evidence
for their participation in neurotransmitter release in neuroen-
docrine cells, although they lack the consensus synaptic protein
interaction (synprint) site allowing N- and P/Q-type VGCC to
bind proteins of the secretion machinery. An increased density
of T-type VGCC is seen as a response to stressors in many cells
and tissues, presumably lowering the action potential firing
Fig. 8. P-STS cells express histamine 1 receptor (H1R), histamine 4 receptor
(H4R), free fatty acid receptor 2 (FFAR2), free fatty acid receptor 2 (FFAR3),
and transient receptor potential channel vanilloid 4 (TRPV4) mRNA. Detec-
tion of mRNAs by reverse transcription-polymerase chain reaction (PCR).
Lanes 7 and 8, no PCR fragment detectable with the primer bank primers
ID209862766c1 and ID373432602c1 for FFAR3 and TRPV4. Lanes 12 and
13, no PCR fragment of TRPV4 detectable with 1.5 and 2.0 mM MgCl2 instead
of 2.5 mM MgCl2 as used in lane 14. TLR4, Toll-like receptor 4.
Fig. 9. P-STS cells express histamine 1 recep-
tor (H1R), transient receptor potential channel
vanilloid 4 (TRPV4), Toll-like receptor 4
(TLR4), and CD14 protein. A and B: immuno-
fluorescence staining of P-STS cells with anti-
H1R (A) or anti-TRPV4 (B) in the presence
(BP) or absence of the corresponding block-
ing peptide and detected with goat Alexa 488-
labeled secondary antibodies (green). C: im-
munofluorescence staining of P-STS cells and
phorbol 12-myristate,13-acetate (PMA)-differ-
entiated THP-1 monocytes/macrophages with
anti-TLR4 detected with goat Alexa 488-la-
beled secondary antibody (green). D: immuno-
fluorescence staining of P-STS cells, HEK 293
cells (supposed to have no CD14) (18), and
PMA-differentiated THP-1 monocytes/macro-
phages with anti-CD14 detected with goat Al-
exa 488-labeled secondary antibody (green).
Blue, nuclei.
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threshold (12). Thus, the importance of T-type VGCC for
histamine-induced and ACh-induced cell activation in P-STS
cells may be a typical feature of human EC cells. T-type
channel blockers have been suggested as promising candidates
for novel analgesics potentially useful for treating visceral pain
and discomfort (3). Otilonium bromide, a spasmolytic with
significant therapeutic effect in IBS and minimal systemic
absorption from the intestine (3, 11, 16, 59), is known to inhibit
T- and L-type VGCC and muscarinic ACh receptors (27, 31).
Accordingly, otilonium bromide effectively inhibited the syn-
ergistic enhancement of the [Ca2]i response to ACh by
histamine and the response to histamine alone, confirming the
results with mibefradil. This suggests that otilonium bromide
might be useful not only in IBS but also in histamine intoler-
ance and food allergy by obviating excessive dietary restric-
tions that might have detrimental effects.
A role in visceral nociception and hypersensitivity, an im-
portant clinical problem for the patients, has been suggested for
TRPA1, TRPV1, and TRPV4 (5, 37). Accordingly, agonists of
these cation channels, including the food constituents capsai-
cin, cinnamaldehyde, and piperine, were tested for their effect
on the [Ca2]i response of P-STS cells in the absence or
presence of ACh, histamine, or both agonists. These experi-
ments gave no indication of the presence of functional TRPA1,
TRPV1, or TRPV4. Because there is evidence suggesting that
TRPV4 expression is increased in the intestine of IBS patients
and that in these patients elevated levels of histamine and
serotonin are implicated in the development of visceral hyper-
sensitivity (reviewed in Refs. 23 and 64), we looked for
expression of TRPV4 in P-STS cells. We detected both TRPV4
mRNA and protein. Further research will be necessary to
clarify why the cells do not react to the TRPV4 agonist
Fig. 10. The p65/RelA protein in P-STS cells shows
no reaction to lipopolysaccharide (LPS). Phorbol 12-
myristate,13-acetate (PMA)-differentiated THP-1 mono-
cytes/macrophages (A) or P-STS (B) cells were grown
on cover glass slides, washed with pure medium,
and incubated for 30 min at 37°C in 200 l of
medium containing 1% heat-inactivated fetal calf
serum (FCS) (phospho-NF-B p65) or in 400 l full
medium (NF-B p65). LPS (1 g/ml) was added,
and the cells were either fixed immediately or fur-
ther incubated at 37°C for the indicated time before
fixation and staining for immunofluorescence with
phospho-NF-B p65(Ser536) or RelA/NF-B p65
detected with a goat Alexa 488-labeled secondary
antibody (green). Merged images with nuclear stain-
ing (blue) are shown for THP-1 cells and phospho-
p65-labeled P-STS cells. As a positive control for
migration of P-STS NF-B p65 in the nucleus, the
cells were treated with 1 mM H2O2 in complete
medium for 30 min and further incubated in medium
without H2O2 for 3 h (B, 2nd row, right).
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GSK-1016790A. Possible explanations include low TRPV4
localization at the cell surface or expression of nonfunctional
TRPV4. In this respect, it is interesting that, in primary human
endothelial cells, most TRPV4 channels remained silent even
during maximal stimulation with GSK-1016790A (56).
There was a weak [Ca2]i response with butyrate when
added together with ACh. Induction of serotonin secretion by
butyrate would be consistent with the necessity for increased
gut motility when microbial activity is high to pursue digestion
and prevent bacterial overgrowth in the small intestine (52).
Short-chain fatty acid concentrations of 70–140 mM have been
observed in the proximal colon (65), and about one-tenth of
this concentration was found in human ileum (17). Short-chain
fatty acids are agonists of the free fatty acid receptors
FFAR2/G protein-coupled receptor 43 and FFAR3/G protein-
coupled receptor 41 and induced a [Ca2]i response when
transfected in Chinese hamster ovary cells (34). They are
involved in hormone secretion by intestinal neuroendocrine
cells (8). Butyrate and FFAR2 have been implicated in sero-
tonin secretion by neuroendocrine cells (2, 47). We show that
P-STS cells express mRNA of both FFAR2 and FFAR3.
Upon addition of glutamate, glutamate plus ACh, or ATI,
there was no [Ca2]i response in P-STS cells. Because the IL-8
response to ATI in human monocyte-derived dendritic cells
depends heavily on TLR4 and CD14 (28), we tested the
response of P-STS cells to LPS, another ligand of the TLR4-
MD-2-CD14 complex. Despite the presence of TLR4 and
CD14 protein confirmed by immunofluorescence microscopy,
the cells showed neither a [Ca2]i response to LPS nor dis-
cernible migration of NF-B p65/RelA or Ser536-phosphory-
lated p65/RelA to the nucleus. Whereas preincubation with
TNF- simulating inflammatory conditions considerably in-
creased the [Ca2]i response to histamine alone, long-term
incubation with ATI or LPS had no such effect. No protein-
altering insertions/deletions or rare single nucleotide polymor-
phisms have been found in the P-STS TLR4 sequence (27). It
is unknown, however, whether P-STS cells express MD-2,
which was critical for LPS responses in intestinal epithelial cell
lines and a CHO cell line (1, 49). In accordance with our
results, in a previous study, LPS evoked only an insignificant
release of serotonin in human EC cells isolated from normal
mucosa, whereas in EC cells from Crohn’s colitis mucosa,
there was an increased serotonin secretion in response to LPS
(31). Control of signaling to commensal microorganisms is
extremely important in the intestinal epithelium. Low expres-
sion of Toll-like receptors and accessory proteins may be a
means of avoiding hyperresponsiveness (61) (reviewed in
Refs. 40 and 58). Additional control mechanisms of TLR
signaling include location of TLRs in intracellular compart-
ments or at the basolateral membrane and negative regulation
of signaling by inhibitory factors. An investigation into the
complexity of this regulatory network in P-STS cells would
exceed the scope of this work.
Recent evidence indicates that LPS can directly activate the
cation channels TRPA1 and TRPV4 and induce an increase in
[Ca2]i (9). Interaction of LPS with TLR4 has been shown to
sensitize TRPV1 to capsaicin (37). These properties of LPS
might be the physiological reason for the lack of functional
TRPA1, TRPV1, and TRPV4 in P-STS cells, since constant
exposition to LPS of cells exposed to the gut lumen otherwise
might activate these channels.
In conclusion, in this work, we show work that, in addition
to H3R and H4R, P-STS ileal EC cells express the H1R and are
also sensitive to histamine in the absence of ACh. Histamine
and ACh together cause a synergistic increase in [Ca2]i that is
inhibited by the spasmolytic otilonium bromide, a drug ame-
liorating symptoms in IBS. Otilonium bromide also inhibits
cell activation by histamine alone. These results suggest that it
might be therapeutically useful in histamine intolerance and
food allergy. Our data indicate that the T-type VGCCs partic-
ipate in the increase in [Ca2]i evoked by histamine, which is
a requirement for serotonin secretion. Pretreatment with
TNF- considerably increased the [Ca2]i response to hista-
mine alone, suggesting that patients with IBD or IBS with a
tendency toward inflammation might have increased suscepti-
bility to histamine and activation of mast cells. The cells
showed no response to wheat amylase-trypsin inhibitors, sug-
gesting that EC cells are not directly involved in nongluten
wheat sensitivity.
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